Catalyst
Slingshot members are tracking this event:
Portola (PTLA) Expects Committee for Medicinal Products for Human Use (CHMP) Opinion in Q4 for Betrixaban in Prevention of VTE in Acute Medically Ill Patients
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PTLA |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 23, 2017
Occurred Source:
http://investors.portola.com/phoenix.zhtml?c=198136&p=irol-newsArticle&ID=2282890
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Chmp, Opinion, Betrixaban, Prevention Of Vte, Acute Medically Ill Patients
